3-(3-BROMO-PHENYL)-2-METHYL-PROPIONIC ACID, 90.0%, 2g

N-Ethylnicotinamide, 98%, 1g

Methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-6-carboxylate, 95.0%, 1g

4-methyl-1H-benzimidazol-2-amine hydrobromide, 95.0%, 1g

5,6-Diamino-1-methyluracil, 95.0%, 1g

4-Chloro-5-fluoro-2-phenylpyrimidine, 97%, 1g

Pentaeritritol, mínimo 98%, para síntesis, 500 g, envase de plástico.

EDT, >98%, 100g

(S)-2-(3,4,5-Trimethoxyphenyl)butanoic acid, 95.0%, 1g

4-CYCLOPROPYLPIPERIDINE HCL, 95.0%, 1g

(2-Methylthiazol-5-yl)methanol, 95.0%, 1g

6-BROMO-4-FLUORO-3-METHYL-1H-INDAZOLE, 95%, 100mg

2,3,5-Trichloropyridine>98.0%(GC)250g